P2 Clinical evaluation of the next-generation sequencing (NGS) for detection of drug-resistance mutations in HIV-1
G. Dessilly,
L. Goeminne,
A. Duquenne,
A.T. Vandenbroucke,
E. André,
F.E. Dufrasne,
A. Martin,
B. Kabamba,
J. Ruelle
Affiliations
G. Dessilly
Université catholique de Louvain, AIDS Reference Laboratory, Institute of Experimental and Clinical Research (IREC), Medical Microbiology Unit (MBLG), Brussels, Belgium
L. Goeminne
Université catholique de Louvain, AIDS Reference Laboratory, Institute of Experimental and Clinical Research (IREC), Medical Microbiology Unit (MBLG), Brussels, Belgium
A. Duquenne
Université catholique de Louvain, AIDS Reference Laboratory, Institute of Experimental and Clinical Research (IREC), Medical Microbiology Unit (MBLG), Brussels, Belgium
A.T. Vandenbroucke
Université catholique de Louvain, AIDS Reference Laboratory, Institute of Experimental and Clinical Research (IREC), Medical Microbiology Unit (MBLG), Brussels, Belgium
E. André
Université catholique de Louvain, AIDS Reference Laboratory, Institute of Experimental and Clinical Research (IREC), Medical Microbiology Unit (MBLG), Brussels, Belgium
F.E. Dufrasne
Université catholique de Louvain, AIDS Reference Laboratory, Institute of Experimental and Clinical Research (IREC), Medical Microbiology Unit (MBLG), Brussels, Belgium
A. Martin
Université catholique de Louvain, AIDS Reference Laboratory, Institute of Experimental and Clinical Research (IREC), Medical Microbiology Unit (MBLG), Brussels, Belgium
B. Kabamba
Université catholique de Louvain, AIDS Reference Laboratory, Institute of Experimental and Clinical Research (IREC), Medical Microbiology Unit (MBLG), Brussels, Belgium
J. Ruelle
Université catholique de Louvain, AIDS Reference Laboratory, Institute of Experimental and Clinical Research (IREC), Medical Microbiology Unit (MBLG), Brussels, Belgium